LeaderVoices with Sadhna Bokhiria
How do you lead with clarity in systems built on complexity? In this episode of LeaderVoices [https://podcast.kiria.co/], Dr. Sadhna Bokhiria [https://sbokhiria.com/] welcomes Dr. Anupam Agarwal [https://www.linkedin.com/in/anupamagarwalmd/]—a physician executive, biotech investor, and board leader whose career bridges medicine, global pharma, and venture capital. With over 19 years in the pharmaceutical industry—across GSK, Pfizer, and Gilead—and more than a decade in academic and clinical practice, Anupam brings a rare, multidimensional lens to the future of healthcare. Now serving as the incoming president of the Harvard Club of San Francisco and a member of the Cardiovascular Science Research Consortium, he continues to shape the next era of science and strategy. This conversation unpacks: * The mindset shift from practicing medicine to leading in industry * How to navigate the ethical tensions of pharma leadership * Why cardiovascular innovation is at an inflection point * What biotech investors look for beyond the pitch deck * And how curiosity, humility, and systems thinking have shaped Anupam's journey Why This Episode Matters Whether you're in healthcare, leadership, or venture—this episode is a front-row seat to how science, business, and purpose can align. Anupam doesn't just talk about innovation—he's lived it. And his reflections offer a masterclass in how to lead when lives, ethics, and billion-dollar decisions are on the line. Top Takeaways * Clinical credibility matters in boardrooms. It earns trust and keeps the patient in the picture. * The best investors aren't just looking for IP—they're looking for mission clarity and people who can navigate ambiguity. * Ethical leadership in pharma means holding tension between innovation, access, and sustainability. * In cardiovascular science, we're on the brink of a new chapter—but it'll take public-private synergy to get there. Timestamps 00:00 – Welcome + Guest intro 04:15 – Leaving the clinic: why Anupam transitioned into industry 08:42 – GSK, Pfizer, Gilead: lessons in leadership from global pharma 14:20 – The ethics of speed and scale in drug development 21:30 – Cardiovascular breakthroughs and unmet needs 29:10 – What makes a biotech venture backable in 2025 35:40 – Advice to early-career physician leaders 41:12 – Closing reflections: staying grounded in curiosity Connect with Dr. Anupam Agarwal LinkedIn [https://www.linkedin.com/in/anupamagarwalmd/] 👉 Subscribe + leave us a review if this episode moved you. It helps more people discover the voices shaping tomorrow's leadership.
28 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de LeaderVoices with Sadhna Bokhiria!